| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |